Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.05 AUD | -0.50% | -2.99% | -16.25% |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Auto, Truck & Motorcycle Parts
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.25% | 936M | C- | ||
+26.07% | 51.05B | B | ||
-9.91% | 22.04B | B | ||
+25.92% | 20.17B | B+ | ||
+33.27% | 17.52B | B | ||
-4.64% | 15.13B | B+ | ||
-18.39% | 13.41B | B | ||
-19.97% | 13.26B | B | ||
+33.81% | 12.25B | B | ||
+28.63% | 10.66B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- GUD Stock
- Ratings GUD Holdings Limited